Other content tagged: RSV
Know the facts in a world full of infectious respiratory viruses
Explore our corporate partner AstraZeneca's new one-stop web resource for respiratory virus knowledge and try the symptom comparator right away. It's that time of year again when coughs and colds are ubiquitous. But is it possible to have several respiratory diseases at the same time? Indeed, this phenomenon is known as coinfection although it is relatively rare due to the competition between the viruses during infection.[1-3] While infrequent, the consequences of coinfection may…
Read more
RSV Policy and Advocacy Workshop in Munich
From 23 to 25 June 2023, parent and patient representatives from all over the world came together to exchange and learn about effective policy and advocacy activities and tools using the example of RSV in young children. It was a pleasure for EFCNI to host this workshop on policy and advocacy in the field of RSV in Munich from 23 to 25 June 2023. The three days were packed with practical exercises, interesting group discussions and workshops to help the…
Read more
New preliminary study results suggest that new RSV antibody may help reduce infant hospitalisation due to RSV
Interesting first preliminary results from the HARMONIE phase 3b trial on the efficacy of Nirsevimab against RSV (respiratory syncytial virus) infection were presented at the 41st Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID) in Lisbon in early May. According to these initial results, a single intramuscular dose of this new monoclonal antibody would significantly reduce the frequency of hospitalisations in infants with RSV-associated lower respiratory tract infections (LRTI), suggesting that…
Read more
Beneficial influence of breastfeeding on Respiratory Syncytial Virus (RSV)-associated acute lower respiratory infections in children – a systematic literature review
The Respiratory Syncytial Virus (RSV) poses a significant risk of serious infection in children worldwide, in particular in children in low-income and middle-income countries. However, previous studies indicated that breastfeeding could be a protective factor as it strengthens the immune system and protects against other serious childhood infections. A current systematic review summarises the available evidence on breastfeeding and its effects on acute lower respiratory infections which are associated with RSV. Breastfeeding is officially…
Read more
Platinum Partner AstraZeneca produced and funded “Sounds of RSV” to support awareness of symptoms
Our partnership with AstraZeneca is part of the EFCNI’s ongoing dedication to raising awareness amongst parents and healthcare professionals about the symptoms of RSV infection and how it can be prevented. With around 33 million acute lower respiratory infections caused each year, RSV infection is one of the most common causes of early life wheezing illness.[1,2] Babies who are born prematurely or who have underlying health issues such as heart or…
Read more
FIRST EXPERT ROUNDTABLE ON RSV PROTECTION FOR ALL INFANTS
In 2021, the season of respiratory syncytial virus (RSV) infections was exceptional in terms of the very early onset and the enormously high numbers of hospitalised children. Thus, the last season showed very clearly: RSV is a major health threat to children under two years of age. In most cases of RSV, children develop only mild, cold-like symptoms. However, a number of children suffer from a severe course of the infection with severe respiratory distress and accompanying symptoms that need…
Read more
EFCNI Welcomes Platinum Partner AstraZeneca to Raise Awareness of RSV
With EFCNI’s long standing leadership in preterm infants’ health and well-being, and AstraZeneca’s heritage in the RSV space, this partnership aims to increase awareness and educate parents and healthcare providers about the signs and symptoms of this challenging condition and available preventative options. In celebration of EFCNI’s platinum partnership with AstraZeneca, we had the opportunity to sit down with three leaders from AstraZeneca’s RSV team to ask about their work within the disease area. RSV is a very common,…
Read more
Fachgesellschaften empfehlen vorgezogene RSV-Prophylaxe nach untypischem Fallanstieg von Kindern mit RSV-bedingten Atemwegsinfektionen
Durch COVID-19-Hygienemaßnahmen und Kontaktbeschränkungen wurden bekannte Grippe- und Erkältungskrankheiten im vergangenen Herbst und Winter zurückgedrängt. Nach Lockerungen der Schutz- und Hygieneregeln nehmen nun auch andere Atemwegsinfektionen wieder zu. Ärzte beobachten derzeit besorgt einen für die Jahreszeit untypischen, verfrühten Anstieg an Krankenhausaufnahmen mit einer hohen Belastung der Kinderkliniken durch Atemwegsinfektionen aufgrund des Respiratorischen Synzytial Virus (RSV). Üblicherweise verläuft die RSV-Saison in Deutschland parallel zu anderen Atemwegsinfekten in den Wintermonaten zwischen November und April. Das RSV ist vor allem für Frühgeborene und Kleinkinder gefährlich,…
Read more
Parental knowledge of respiratory infections in preterm infants
A survey among parents regarding their understanding of respiratory syncytial virus (RSV) and other respiratory infections in preterm babies showed a highly established knowledge. Most parents consider RSV illness a very serious condition and identified nurses, doctors, and pamphlets as their primary sources of information. The Canadian Premature Babies Foundation (CPBF), a parent-led organisation, strives to minimise the overwhelming challenges of families of preterm babies through the provision of evidence-based information. These educational mandates,…
Read more
